Shares of Yumanity Therapeutics, Inc. (NASDAQ:YMTX – Get Free Report) shot up 3.4% on Thursday . The company traded as high as $0.64 and last traded at $0.58. 29,139 shares changed hands during trading, a decline of 94% from the average session volume of 473,083 shares. The stock had previously closed at $0.56.
Yumanity Therapeutics Price Performance
The firm has a 50-day simple moving average of $0.61 and a 200 day simple moving average of $0.90. The company has a market capitalization of $6.12 million, a PE ratio of -0.19 and a beta of 0.32.
About Yumanity Therapeutics
Yumanity Therapeutics Inc, a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis, and frontotemporal lobar degeneration.
See Also
- Five stocks we like better than Yumanity Therapeutics
- Dividend Capture Strategy: What You Need to Know
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- ETF Screener: Uses and Step-by-Step Guide
- MarketBeat Week in Review – 8/12 – 8/16
- Retail Stocks Investing, Explained
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for Yumanity Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yumanity Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
